ADIPOQ and cryohydrocytosis: However, how adiponectin levels evolve after SVR in CHC patients following DAA therapy remained unidentified and is crucial for the patients' prognosis, since interferon-based therapy had been replaced by DAA therapy as the standard of care treatment for CHC currently [26].